Back to search

Peptide record

TPDB08314

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08314
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb
standard
No
A 16-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
VVKCSYRLGSPDSQCN
Physicochemical Analysis
C72H118N22O25S2
AEHIMFTW
S
1755.98
8.28
2
1
4
+1
3.04
-0.463
60.62
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
1615
91.97
8
Residue Composition
number
0
A
1
R
1
N
1
D
2
C
0
E
1
Q
1
G
0
H
0
I
1
L
1
K
0
M
0
F
1
P
3
S
0
T
0
W
1
Y
2
V
Amino Acid Distribution
A: 0 R: 1 N: 1 D: 1 C: 2 E: 0 Q: 1 G: 1 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 1 S: 3 T: 0 W: 0 Y: 1 V: 2
Chemical Descriptors
16
C72H118N22O25S2
1755.98
8.28
+1
3.04
-0.463
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
35.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- bacteria E. coli (MIC 35.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 2 Activity

Activity

MIC
Antibacterial
35.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

IC 35.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC 35.2 ug/ml), and yeast C. albicans (MIC 17.6 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
17.6 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

led P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC 35.2 ug/ml), and yeast C. albicans (MIC 17.6 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
35.2 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- bacteria E. coli (MIC 35.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 5 Activity

Activity

MIC
Antifungal
35.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

IC 35.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC 35.2 ug/ml), and yeast C. albicans (MIC 17.6 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
17.6 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

led P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC 35.2 ug/ml), and yeast C. albicans (MIC 17.6 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
35.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- bacteria E. coli (MIC 35.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 8 Activity

Activity

MIC
Antiparasitic
35.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

IC 35.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC 35.2 ug/ml), and yeast C. albicans (MIC 17.6 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
17.6 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

led P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC 35.2 ug/ml), and yeast C. albicans (MIC 17.6 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
35.2 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram- bacteria E. coli (MIC 35.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 11 Activity

Activity

MIC
Antiviral
35.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

IC 35.2 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC 35.2 ug/ml), and yeast C. albicans (MIC 17.6 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
17.6 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

led P. aeruginosa) (MIC 17.6 ug/ml), Gram+ bacteria S. aureus (MIC 35.2 ug/ml), and yeast C. albicans (MIC 17.6 ug/ml). Updated 7/2021